KEGG DRUG: Trafermin (original) (raw)
| 
| | DRUG: Trafermin |
| ------------------------------------------------------------- | | --------------- |
| Entry | D03362 Drug |
|---|---|
| Name | Trafermin (USAN/INN);Trafermin (genetical recombination) (JAN);Fiblast (TN) |
| Formula | C764H1201N217O219S6 |
| Exact mass | 17111.7837 |
| Mol weight | 17122.44 |
| Remark | Therapeutic category: 1329 2699 2790ATC code: D03AX15Product: D03362<JP> |
| Efficacy | Anti-ulcerative (skin), Periodontal guided tissue regeneraion agent, Stroke treatment |
| Comment | Fibroblast growth factor |
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] D DERMATOLOGICALS D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS D03A CICATRIZANTS D03AX Other cicatrizants D03AX15 Trafermin D03362 Trafermin (USAN/INN) Therapeutic category of drugs in Japan [BR:br08301] 1 Agents affecting nervous system and sensory organs 13 Agents affecting sensory organs 132 Otic and nasal agents 1329 Others D03362 Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN) 2 Agents affecting individual organs 26 Epidermides 269 Miscellaneous 2699 Others D03362 Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN) 27 Dental preparations 279 Miscellaneous 2790 Miscellaneous D03362 Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)New drug approvals in Japan [br08318.html] Drugs with new active ingredients D03362 |
| Other DBs | CAS: 131094-16-1PubChem: 17397511NIKKAJI: J2.194.593E |
| LinkDB |